Canada's health regulatory body, Health Canada has given its approval for a new device developed in collaboration between British Columbia Cancer Agency and the University of British Columbia's Faculty of Medicine. This device can help in the early detection of skin cancer.
Known as The Aura, the device will be commercialized by local spin-off firm Verisante and can be used by any health professional to detect skin cancer instead of a qualified dermatologist.
AdvertisementThe company said that the Aura will be able to provide an early diagnosis of skin cancer and will help reduce the waiting times, thereby increasing the number of people that can be screened.
You May Also Like